SRRK241018C12500
- 19.25
- 0.000.00%
Scholar Rock Newsroom
A Quick Look at Today's Ratings for Scholar Rock(SRRK.US), With a Forecast Between $27 to $36
Nasdaq To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Scholar Rock's Spinal Muscular Atrophy Drug Plans for Children Under 2 Could Broaden Patient Group, Truist Says
Stocks Gain Pre-Bell as Traders Gear Up for Latest Earnings Season; Asia Churns, Europe Down
Scholar Rock Stocks Skyrocket After SMA Drug Scores at Phase III
Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co.
Scholar Rock Holding Price Target Raised to $35.00/Share From $30.00 by HC Wainwright & Co.
Scholar Rock(SRRK.US) Officer Sells US$5.48 Million in Common Stock
Scholar Rock (SRRK.US) stock price soared 335%, with candidate SMA drug successfully passing the third stage of trials.
Scholar Rock Holding Corp.'s stock price surged 335% in Monday's trading session.
Scholar Rock(SRRK.US) Director Sells US$34.39 Million in Common Stock
Form 144 | Scholar Rock(SRRK.US) Director Proposes to Sell 34.39 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 7, $Scholar Rock(SRRK.US)$ Director AKKARAJU SRINIVAS intends to sell 1.18 million shares of its common stock on Oct 7, with a total market value of approximately $34.39
Health Care Losses Limited By Defensive Bias - Health Care Roundup
After-hours Movers: PENN Entertainment, Scholar Rock, and More
Scholar Rock Announces $275M Common Stock Offering
Express News | Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Express News | Scholar Rock Holding Corp Files for Mixed Shelf; Size Not Disclosed-SEC Filing
Market Falls Monday to Start the First Week of Q3 Earnings | Wall Street Today
Scholar Rock SRRK Phase 3 Success; Oncolytics ONCY Accelerated Pathway
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge
How Is The Market Feeling About Scholar Rock Holding?